Close

Analyst Ratings for Bristol-Myers Squibb Co. (BMY) [Buys]

BMY Rating Summary

BMY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BMY
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $77.86 (+5%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/17/2021 Goldman Sachs
» Updated 2/7/2022
Chris Shibutani New Coverage Buy
(N/A)
76.00
(74.00)
62.17
(74.15)
19.27% Details
11/19/2021 BMO Capital
» Updated 5/2/2022
Evan David Seigerman New Coverage Outperform
(N/A)
92.00
(87.00)
59.44
(74.15)
24.75% Details
Like BMY Ratings? Also take a look at CELG, TPTX, NKTR, IMTX

BMY Ratings News